This inventor holds 20 USPTO granted patents and 19 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Organoid Technology. Top assignees: Koninklijke Nederlandse Akademie Van Wetenschappen, Umc Utrecht Holding B.v., Fundacio Institut De Recerca Biomedica. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Utrect, NL (2020)
- Huis ter Heide, NL (2014 - 2021)
- Amsterdam, NL (2021)
- CT Utrecht, NL (2018 - 2023)
- Utrecht, NL (2023 - 2024)
Company Filing History:
18 out of 30 
3 out of 53 
1 out of 1 
Years Active: 2014-2026
Areas of Expertise:
Title: The Innovative Mind of Johannes Carolus Clevers
Introduction
Johannes Carolus Clevers, based in Huis ter Heide, Netherlands, is a remarkable inventor and scientist recognized for his significant contributions to medical research and diagnostics. With a portfolio of 15 patents, his work primarily focuses on innovative solutions in the fields of disease diagnosis and cancer treatment.
Latest Patents
Clevers' latest patents include a groundbreaking rapid quantitative test to diagnose polycystic kidney disease. This invention relates to an assay designed to diagnose disorders affecting fluid uptake or secretion, or for assessing the efficacy of drugs treating such conditions by measuring swelling in organoids. Another notable patent is for binding molecules that inhibit cancer growth. This patent offers methods for halting cancer development using proteins and antibodies that bind to specific members of the epidermal growth factor receptor family and parts associated with the WNT signaling pathway, alongside providing essential cells and assays for developing these proteins and antibodies.
Career Highlights
Throughout his career, Clevers has worked with prestigious institutions, including the Royal Netherlands Academy of Arts and Sciences and UMC Utrecht Holding B.V. His position in these organizations has allowed him to pioneer critical advancements in medical science, especially concerning organoid technology and cancer research.
Collaborations
Collaboration has been a key aspect of Clevers' success. He has worked closely with esteemed colleagues such as Meritxell Huch Ortega and Toshiro Sato. These partnerships demonstrate his commitment to advancing research and developing innovative solutions in healthcare.
Conclusion
Johannes Carolus Clevers stands out as a leading figure in the realm of medical inventions. His dedication to innovation and collaboration continues to pave the way for new diagnostic techniques and therapies, making a significant impact on the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile